SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10 - Q/A
AMENDMENT TO REPORT
Filed pursuant to Section 13 or 15 (d) of
THE SECURITIES EXCHANGE ACT OF 1934
MEDICAL ACTION INDUSTRIES INC.
------------------------------
(Exact name of registrant as specified in charter)
AMENDMENT NO. 1
The undersigned registrant hereby amends the Statement of Earnings for
the Three Months Ended June 30, 1999 to correct a typographical error in the
cost of sales line only, of its Quarterly Report on Form 10-Q for the quarter
ended June 30, 1999 as set forth in the pages attached hereto:
Item 1 - Financial Statements
------
(a) Statement of Earnings for the Three Months Ended June 30, 1999
and 1998 (Unaudited)
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this amendment to be signed on its behalf by the
undersigned thereunto duly authorized.
MEDICAL ACTION INDUSTRIES INC.
------------------------------
(Registrant)
Date: September 1, 1999 By: /s/ Richard G. Satin
-------------------- ---------------------------------
Richard G. Satin
(Principal Accounting Officer)
MEDICAL ACTION INDUSTRIES INC.
------------------------------
Statements of Earnings
----------------------
(dollars in thousands except per share data)
Three Months Ended
June 30,
1999 1999
---- ----
(Unaudited) (Unaudited)
Net Sales $ 17,913 $ 14,139
Cost of Sales 13,435 10,926
---------- ----------
Gross Profit 4,478 3,213
Selling, general and administrative
expenses 3,130 2,359
Interest expense 234 170
---------- ------------
Income before income taxes 1,114 684
Income tax expense 434 270
------------ -----------
Net income $ 680 $ 414
=========== ===========
Basic and diluted earnings per share $ .08 $ .05
============ ==========
The accompanying notes are an integral part of these financial statements.
5